Your browser doesn't support javascript.
loading
CSF3R T618I mutant myelodysplastic/myeloproliferative neoplasm in the elderly: An age-related disease with unfavorable prognosis.
Zhang, Xinmin; Ghiuzeli, Cristina; Jou, Erin; Hsu, Peihong; Kolitz, Jonathan; Brody, Judith P.
Afiliação
  • Zhang X; Department of Pathology and Laboratory Medicine, United States.
  • Ghiuzeli C; Northwell Cancer Institute, Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, United States.
  • Jou E; Northwell Cancer Institute, Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, United States.
  • Hsu P; Department of Pathology and Laboratory Medicine, United States.
  • Kolitz J; Northwell Cancer Institute, Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, United States.
  • Brody JP; Department of Pathology and Laboratory Medicine, United States.
Leuk Res Rep ; 17: 100334, 2022.
Article em En | MEDLINE | ID: mdl-35795468
ABSTRACT
We reported two MDS/MPN-U and one CMML patients with CSF3R T618I mutation. There were two males and one female, with a median age of 84 years. Three patients presented with leukocytosis and anemia, two with thrombocytopenia, and one with monocytosis. In all the patients, bone marrow showed hypercellularity with myeloid or erythroid predominant trilineage hematopoiesis and dysplasia. Two cases carried -7/-7q abnormalities. In addition to CSF3R T618/I mutation, each case carried 3-5 additional somatic mutations. The median survival was only 2 months. These rare patients were characterized by old age, high mutation rates, clonal hematopoiesis-associated mutations, clonal evolution, and unfavorable prognosis.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article